Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

. 2024 May 21 ; 45 (19) : 1733-1737.

Jazyk angličtina Země Velká Británie, Anglie Médium print

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid38591192

Grantová podpora
BMBF
German Ministry of Education and Research
DZHK
Daiichi Sankyo Europe
633196 European Union
847770 AFNET
965286 MAESTRIA
AA/18/2/34218 British Heart Foundation - United Kingdom
German Research Foundation
01-002-2022-0118 Dutch Heart Foundation

Atrial Fibrillation NETwork Muenster Germany

Biomedical Research Foundation Academy of Athens Greece and Hygeia Hospitals Group Athens Greece

Biostatistics Lab School of Medicine University of Crete Crete Greece

Cardiac Department John Radcliffe Hospital Oxford University Hospitals NHS Foundation Trust Oxford UK

Cardiology Division European Georges Pompidou Hospital Paris France

Cardiology Unit Camposampiero Hospital AULSS Euganea Italy

Cardiovascular and Genetics Research Institute St George's University of London London UK

Centre for Patient Reported Outcomes Research Institute of Applied Health Research University of Birmingham Edgbaston Birmingham UK

Centro de Investigacion Biomedica en Red Cardiovascular Madrid Spain

Danish Center for Health Services Research Department of Clinical Medicine Aalborg University Aalborg Denmark

Department of Cardiology and Intensive Care Medicine St Vincenz Hospital Paderborn Paderborn Germany

Department of Cardiology and Internal Diseases Medical University of Gdańsk Gdańsk Poland

Department of Cardiology Department of Regional Health Research Esbjerg Hospital University Hospital of Southern Denmark University of Southern Denmark Esbjerg Denmark

Department of Cardiology Heraklion University Hospital Heraklion Crete Greece

Department of Cardiology Hospital Clinic Universtitat de Barcelona Catalonia Spain

Department of Cardiology Institute for Clinical and Experimental Medicine Prague Czechia

Department of Cardiology School of Medical Sciences Faculty of Medicine and Health Örebro University Örebro Sweden

Department of Cardiology University Heart and Vascular Center Hamburg University Medical Center Hamburg Eppendorf Martinistrasse 52 20246 Hamburg Germany

Department of Cardiology University Hospital Antwerp Edegem Belgium

Department of Internal Medicine 3 Cardiology and Angiology Innsbruck Medical University Innsbruck Austria

Department of Medical Science Uppsala University Uppsala Sweden

Department of Neuroepidemiology Institute for Medical Informatics Biometry and Epidemiology University Duisburg Essen Essen Germany

Departments of Cardiology and Physiology Maastricht University Maastricht The Netherlands

Division of Cardiology Medical University of Graz Austria

German Center for Cardiovascular Research Partner Site Hamburg Kiel Luebeck Hamburg Germany

Heart and Vascular Centre Semmelweis University Budapest Hungary

Institut d'Investigacions Biomèdiques August Pi Sunyer Barcelona Catalonia Spain

Institute of Medical Biometry and Epidemiology University Medical Centre Hamburg Eppendorf Germany

Liverpool Centre for Cardiovascular Science at University of Liverpool Liverpool John Moores University and Liverpool Heart and Chest Hospital Liverpool UK

Medicine University 'Carol Davila' Colentina University Hospital Bucharest Romania

NIHR Birmingham Biomedical Research Centre and NIHR Applied Research Collaboration West Midlands University of Birmingham Edgbaston Birmingham UK

Otto von Guericke Universität Magdeburg Magdeburg Germany

The Heart Center Department of Clinical and Experimental Cardiology Amsterdam Cardiovascular Sciences Amsterdam University Medical Centers University of Amsterdam Amsterdam The Netherlands

Zobrazit více v PubMed

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. . 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42:373–498. 10.1093/eurheartj/ehaa612 PubMed DOI

Kirchhof P, Toennis T, Goette A, Camm AJ, Diener HC, Becher N, et al. . Anticoagulation with edoxaban in patients with atrial high-rate episodes. N Engl J Med 2023;389:1167–79. 10.1056/NEJMoa2303062 PubMed DOI

Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, McIntyre WF, et al. . Apixaban for stroke prevention in subclinical atrial fibrillation. N Engl J Med 2024;390:107–17. 10.1056/NEJMoa2310234 PubMed DOI

Becher N, Toennis T, Bertaglia E, Blomstrom-Lundqvist C, Brandes A, Cabanelas N, et al. . Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥ 24 h. Eur Heart J 2024;45:837–49. 10.1093/eurheartj/ehad771 DOI

McIntyre WF, Benz AP, Becher N, Healey JS, Granger CB, Rivard L, et al. . Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials. Circulation 2024;149:981–8. 10.1161/CIRCULATIONAHA.123.067512 PubMed DOI

Diederichsen SZ, Haugan KJ, Brandes A, Lanng MB, Graff C, Krieger D, et al. . Natural history of subclinical atrial fibrillation detected by implanted loop recorders. J Am Coll Cardiol 2019;74:2771–81. 10.1016/j.jacc.2019.09.050 PubMed DOI

Kaplan RM, Koehler J, Ziegler PD, Sarkar S, Zweibel S, Passman RS. Stroke risk as a function of atrial fibrillation duration and CHA2DS2-VASc score. Circulation 2019;140:1639–46. 10.1161/CIRCULATIONAHA.119.041303 PubMed DOI

Vanassche T, Lauw MN, Eikelboom JW, Healey JS, Hart RG, Alings M, et al. . Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. Eur Heart J 2015;36:281–8. 10.1093/eurheartj/ehu307 PubMed DOI

Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, et al. . Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med 2020;383:1305–16. 10.1056/NEJMoa2019422 PubMed DOI

Eckardt L, Sehner S, Suling A, Borof K, Breithardt G, Crijns H, et al. . Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial. Eur Heart J 2022;43:4127–44. 10.1093/eurheartj/ehac471 PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...